Halia Therapeutics: Funding, Investors & Team (Sep 2026)
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments for inflammatory disorders and neurological diseases. The company aims to enhance patient well-being by creating innovative medicines that target the immune system's response to address chronic inflammation and counteract the harm caused by improperly activated immune responses. Halia Therapeutics stands out for its unique approach to drug discovery, utilizing the latest insights on the role of inflammation in various human diseases like cancer and neurodegenerative disorders.
Halia Therapeutics has raised $3.8M across 2 funding rounds on record, the most recent a Convertible Note of $3.5M announced in Aug 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Halia Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Halia Therapeutics Funding Rounds
Halia Therapeutics raised $340k in an undisclosed round announced in Jul 2025.
1.1 years later, a Convertible Note of $3.5M was announced in Aug 2026.
Halia Therapeutics Investors
Halia Therapeutics Founders and Leadership Team
Contact details for the Halia Therapeutics team: 3 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Halia Therapeutics Funding Compared to Other Biotechnology Startups
Halia Therapeutics' latest round of $3.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Halia Therapeutics in Biotechnology and Lehi
Companies Similar to Halia Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Halia Therapeutics Funding FAQs
What does Halia Therapeutics do?
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments for inflammatory disorders and neurological diseases. The company aims to enhance patient well-being by creating innovative medicines that target the immune system's response to address chronic inflammation and counteract the harm caused by improperly activated immune responses. Halia Therapeutics stands out for its unique approach to drug discovery, utilizing the latest insights on the role of inflammation in various human diseases like cancer and neurodegenerative disorders.
How much funding has Halia Therapeutics raised?
Halia Therapeutics has raised $3.8M across 2 rounds on record. The most recent is a Convertible Note of $3.5M announced in Aug 2026.
When did Halia Therapeutics last raise funding?
Halia Therapeutics' most recent funding round on record is a Convertible Note of $3.5M, announced in Aug 2026.
Who has invested in Halia Therapeutics?
Investors on record for Halia Therapeutics include Todd Pedersen.
Who founded Halia Therapeutics?
FundedIQ lists Jared Bearss (Founder) at Halia Therapeutics.
Where is Halia Therapeutics headquartered?
Halia Therapeutics is based in Lehi, Utah, United States.
How many employees does Halia Therapeutics have?
Halia Therapeutics is in the 11-50 employee band.
When was Halia Therapeutics founded?
Halia Therapeutics was founded in 2017.
How does Halia Therapeutics' funding compare to other Biotechnology startups?
Halia Therapeutics' latest round of $3.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Halia Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Halia Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.